HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarBacktestsPricing
Theme
Help Login Register
Market News Stocks News ETF News Crypto News

Muhammad Ali Khalid

Contributing Author

Recent Articles by Muhammad Ali Khalid

3 hours
Why Analysts Favor Kiniksa Pharmaceuticals (KNSA) KNSA Insider Monkey
3 hours
Here is What Analysts Have to Say About Hinge Health (HNGE) HNGE Insider Monkey
3 hours
AI-Enabled Automation Driving Up Sentiment Towards Waystar (WAY) WAY Insider Monkey
3 hours
Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) PRCT Insider Monkey
3 hours
BEACON Trial Data Makes Beam Therapeutics (BEAM) an Attractive Buy BEAM Insider Monkey
3 hours
Why Analysts are Rating Alkermes (ALKS) a Buy ALKS Insider Monkey
3 hours
Mizuho Securities Reaffirm Bullish Stance on Surgery Partners (SGRY) SGRY Insider Monkey
3 hours
Why Analysts See a Huge Upside for Dyne Therapeutics (DYN) DYN Insider Monkey
3 hours
What Makes Vaxcyte (PCVX) So Attractive PCVX Insider Monkey
3 hours
Here is Why H.C. Wainwright Sees Immense Upside for Viking Therapeutics (VKTX) VKTX Insider Monkey
3 hours
Here is Why Legend Biotech (LEGN) Offers Such Promising Upside LEGN Insider Monkey
4 hours
Is Denali Therapeutics (DNLI) the Most Promising Mid-Cap Healthcare Stock Under $50? DNLI Insider Monkey
4 hours
Why BofA Sees Strong Upside for Doximity (DOCS) DOCS Insider Monkey
4 hours
2026 Medical Utilization Forecasts Support BTIG's Bullish View on LifeStance (LFST) LFST Insider Monkey
4 hours
Analysts See an Over 26% Upside in AtriCure (ATRC) ATRC Insider Monkey
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Learn more about FINVIZ*Elite